Skip to main content

Recent Sentinel Activity

This recent activity feed provides a list of the last 90 days of Sentinel activity across assessments, publications & presentations, projects, events, etc.

RSS Feed

URL Title Category Date Recent Activity
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/34th-international-conference-pharmacoepidemiology-and 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management Sentinel Initiative Events
34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management
Sentinel Initiative Events
https://sentinelinitiative.org/methods-data-tools/methods/near-real-time-monitoring-critical-drugs-care-patients-covid-19 Near Real-Time Monitoring of Critical Drugs for the Care of Patients with COVID-19 Methods, Data, & Tools
Near Real-Time Monitoring of Critical Drugs for the Care of Patients with COVID-19
Methods, Data, & Tools
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/36th-international-conference-pharmacoepidemiology-and 36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management Publications and Presentations
36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management
Publications and Presentations
https://sentinelinitiative.org/news-events/publications-presentations/covid-19-ready-public-health-surveillance-system-food-and A COVID‐19‐Ready Public Health Surveillance System: The Food and Drug Administration's Sentinel System Publications and Presentations
A COVID‐19‐Ready Public Health Surveillance System: The Food and Drug Administration's Sentinel System
Publications and Presentations
https://sentinelinitiative.org/methods-data-tools/methods/extending-machine-learning-methods-development-sentinel-follow-analyses Extending Machine Learning Methods Development in Sentinel: Follow-up Analyses for Anaphylaxis Algorithm and Formalization of a General Phenotyping Framework (Phase 3) Methods, Data, & Tools
Extending Machine Learning Methods Development in Sentinel: Follow-up Analyses for Anaphylaxis Algorithm and Formalization of a General Phenotyping Framework (Phase 3)
Methods, Data, & Tools
https://sentinelinitiative.org/methods-data-tools/methods/improving-probabilistic-phenotyping-incident-outcomes-through-enhanced Improving Probabilistic Phenotyping of Incident Outcomes through Enhanced Ascertainment with Natural Language Processing Methods, Data, & Tools
Improving Probabilistic Phenotyping of Incident Outcomes through Enhanced Ascertainment with Natural Language Processing
Methods, Data, & Tools
https://sentinelinitiative.org/methods-data-tools/methods/using-unsupervised-learning-harmonize-data-across-data-systems Using Unsupervised Learning to Harmonize Data Across Data Systems Methods, Data, & Tools
Using Unsupervised Learning to Harmonize Data Across Data Systems
Methods, Data, & Tools
https://sentinelinitiative.org/news-events/publications-presentations/strategies-use-real-world-data-conduct-covid-19-related Strategies for the Use of Real-World Data to Conduct COVID-19-Related Pharmacoepidemiology Publications and Presentations
Strategies for the Use of Real-World Data to Conduct COVID-19-Related Pharmacoepidemiology
Publications and Presentations
https://sentinelinitiative.org/methods-data-tools/methods/making-medicaid-data-more-accessible-through-common-data-models-and-fhir Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs Methods, Data, & Tools
Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs
Methods, Data, & Tools
https://sentinelinitiative.org/methods-data-tools/methods/development-and-illustration-framework-conducting-nonrandomized-studies Development and Illustration of a Framework for Conducting Nonrandomized Studies of Medication Safety and Effectiveness Using Healthcare Databases Methods, Data, & Tools
Development and Illustration of a Framework for Conducting Nonrandomized Studies of Medication Safety and Effectiveness Using Healthcare Databases
Methods, Data, & Tools
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/n-nitrosodimethylamine-ndma-contaminated-and-non-ndma N‐nitrosodimethylamine (NDMA)‐Contaminated and Non‐NDMA‐Contaminated Valsartan Use: A Descriptive Analysis Analyses
N‐nitrosodimethylamine (NDMA)‐Contaminated and Non‐NDMA‐Contaminated Valsartan Use: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/incidence-and-prevalence-n-nitrosodimethylamine-ndma-and-n Incidence and Prevalence of N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA) Contaminated Valsartan Use: A Descriptive Analysis Analyses
Incidence and Prevalence of N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA) Contaminated Valsartan Use: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/methods-data-tools/methods/augmenting-date-death-cause-death-ascertainment-sentinel Augmenting Date of Death & Cause of Death Ascertainment in Sentinel Methods, Data, & Tools
Augmenting Date of Death & Cause of Death Ascertainment in Sentinel
Methods, Data, & Tools
https://sentinelinitiative.org/news-events/publications-presentations/impact-nitrosamine-contamination-recalls-angiotensin Impact of Nitrosamine Contamination Recalls on Angiotensin-Receptor-Blocker (ARB) Utilization in the U.S., U.K., Canada, and Denmark Publications and Presentations
Impact of Nitrosamine Contamination Recalls on Angiotensin-Receptor-Blocker (ARB) Utilization in the U.S., U.K., Canada, and Denmark
Publications and Presentations
https://sentinelinitiative.org/methods-data-tools/methods/inclusion-semi-structured-and-unstructured-electronic-health-record-ehr Inclusion of Semi-Structured and Unstructured Electronic Health Record (EHR) Data in Confounding Adjustment and Outcome Ascertainment Methods, Data, & Tools
Inclusion of Semi-Structured and Unstructured Electronic Health Record (EHR) Data in Confounding Adjustment and Outcome Ascertainment
Methods, Data, & Tools
https://sentinelinitiative.org/methods-data-tools/methods/development-and-evaluation-electronic-health-record-ehr-information Development and Evaluation of Electronic Health Record (EHR) Information Extraction Pipeline and Tree-Based Scan Statistic (TBSS) Methods for EHR-Based Signal Detection (DA2) Methods, Data, & Tools
Development and Evaluation of Electronic Health Record (EHR) Information Extraction Pipeline and Tree-Based Scan Statistic (TBSS) Methods for EHR-Based Signal Detection (DA2)
Methods, Data, & Tools
https://sentinelinitiative.org/news-events/publications-presentations/valsartan-losartan-and-irbesartan-use-usa-uk-canada-and Valsartan, Losartan and Irbesartan Use in the USA, UK, Canada and Denmark After the Nitrosamine Recalls: A Descriptive Cohort Study Publications and Presentations
Valsartan, Losartan and Irbesartan Use in the USA, UK, Canada and Denmark After the Nitrosamine Recalls: A Descriptive Cohort Study
Publications and Presentations
https://sentinelinitiative.org/methods-data-tools/methods/subset-calibration-methods Subset Calibration Methods Methods, Data, & Tools
Subset Calibration Methods
Methods, Data, & Tools
https://sentinelinitiative.org/news-events/publications-presentations/treatment-and-care-received-children-hospitalized-covid-19 Treatment and Care Received by Children Hospitalized with COVID-19 in a Large Hospital Network in the United States, February 2020 to September 2021 Publications and Presentations
Treatment and Care Received by Children Hospitalized with COVID-19 in a Large Hospital Network in the United States, February 2020 to September 2021
Publications and Presentations
https://sentinelinitiative.org/methods-data-tools/methods/utilization-single-and-multiple-inhaler-triple-therapy-among-patients Utilization of Single and Multiple Inhaler Triple Therapy Among Patients with COPD in the Sentinel Distributed Database Methods, Data, & Tools
Utilization of Single and Multiple Inhaler Triple Therapy Among Patients with COPD in the Sentinel Distributed Database
Methods, Data, & Tools
https://sentinelinitiative.org/news-events/publications-presentations/high-dose-dexamethasone-covid-19-not-common-large-us High Dose Dexamethasone for COVID-19 Not Common in a Large US Hospital Network Publications and Presentations
High Dose Dexamethasone for COVID-19 Not Common in a Large US Hospital Network
Publications and Presentations
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2023-public-workshop-optimizing-use-postapproval-pregnancy 2023 Public Workshop: Optimizing the Use of Postapproval Pregnancy Safety Studies Sentinel Initiative Events
2023 Public Workshop: Optimizing the Use of Postapproval Pregnancy Safety Studies
Sentinel Initiative Events
https://sentinelinitiative.org/methods-data-tools/methods/empirical-application-sentinel-electronic-health-record-ehr-and-claims Empirical Application of the Sentinel Electronic Health Record (EHR) and Claims Data Partner Network to Address ARIA Insufficient Inferential Requests Methods, Data, & Tools
Empirical Application of the Sentinel Electronic Health Record (EHR) and Claims Data Partner Network to Address ARIA Insufficient Inferential Requests
Methods, Data, & Tools
https://sentinelinitiative.org/methods-data-tools/methods/development-and-refinement-toolkit-large-scale-covariate-adjustment Development and Refinement of a Toolkit for Large Scale Covariate Adjustment in the Electronic Health Record and Claims Data Partner Network Methods, Data, & Tools
Development and Refinement of a Toolkit for Large Scale Covariate Adjustment in the Electronic Health Record and Claims Data Partner Network
Methods, Data, & Tools
https://sentinelinitiative.org/methods-data-tools/methods/incorporate-range-frequently-used-engineering-features-ehrs-sentinel Incorporate a Range of Frequently Used Engineering Features from EHRs into the Sentinel Common Data Model in the Sentinel EHR and Claims Linked Data Partner Network Methods, Data, & Tools
Incorporate a Range of Frequently Used Engineering Features from EHRs into the Sentinel Common Data Model in the Sentinel EHR and Claims Linked Data Partner Network
Methods, Data, & Tools
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-gimoti-metoclopramide-nasal-spray-0 Characterization of Gimoti (Metoclopramide Nasal Spray) Dispensing Patterns: A Second Descriptive Analysis Analyses
Characterization of Gimoti (Metoclopramide Nasal Spray) Dispensing Patterns: A Second Descriptive Analysis
Analyses
https://sentinelinitiative.org/news-events/publications-presentations/validity-inpatient-electronic-health-record-based-measures Validity of Inpatient Electronic Health Record-Based Measures of Oxygen-Related Therapy in the United States: Lessons Applicable for Studying COVID-19 Endpoints Publications and Presentations
Validity of Inpatient Electronic Health Record-Based Measures of Oxygen-Related Therapy in the United States: Lessons Applicable for Studying COVID-19 Endpoints
Publications and Presentations
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characteristics-and-drug-utilization-pregnant-patients-covid Characteristics and Drug Utilization in Pregnant Patients With COVID-19: A Propensity Score Matched Analysis Analyses
Characteristics and Drug Utilization in Pregnant Patients With COVID-19: A Propensity Score Matched Analysis
Analyses
https://sentinelinitiative.org/news-events/publications-presentations/high-dimensional-multiple-imputation-hdmi-strategies High-Dimensional Multiple Imputation (hdMI) Strategies for Partially Observed Confounders with Structured and Natural Language Processing-Derived Auxiliary Covariates Publications and Presentations
High-Dimensional Multiple Imputation (hdMI) Strategies for Partially Observed Confounders with Structured and Natural Language Processing-Derived Auxiliary Covariates
Publications and Presentations
https://sentinelinitiative.org/news-events/publications-presentations/characterizing-inpatient-electronic-health-records-ehr-large Characterizing Inpatient Electronic Health Records (EHR) from a Large Hospital Network for Use in Neonatal Pharmacoepidemiology Studies in the United States Publications and Presentations
Characterizing Inpatient Electronic Health Records (EHR) from a Large Hospital Network for Use in Neonatal Pharmacoepidemiology Studies in the United States
Publications and Presentations
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-guselkumab-use-active Outcome Monitoring Following Guselkumab Use: An Active Comparator Signal Identification Analysis Analyses
Outcome Monitoring Following Guselkumab Use: An Active Comparator Signal Identification Analysis
Analyses
https://sentinelinitiative.org/news-events/publications-presentations/exposure-valsartan-products-containing-nitrosamine Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark Publications and Presentations
Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark
Publications and Presentations
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-risankizumab-use-supplemental Outcome Monitoring Following Risankizumab Use: A Supplemental Signal Identification Analysis Analyses
Outcome Monitoring Following Risankizumab Use: A Supplemental Signal Identification Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-risankizumab-use-signal Outcome Monitoring Following Risankizumab Use: A Signal Identification Analysis Analyses
Outcome Monitoring Following Risankizumab Use: A Signal Identification Analysis
Analyses
https://sentinelinitiative.org/news-events/publications-presentations/applications-real-world-data-rwd-fda-s-sentinel-system Applications of Real-World Data (RWD) in FDA’s Sentinel System Publications and Presentations
Applications of Real-World Data (RWD) in FDA’s Sentinel System
Publications and Presentations
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-guselkumab-use-self-controlled Outcome Monitoring Following Guselkumab Use: A Self-Controlled Risk Interval Signal Identification Analysis Analyses
Outcome Monitoring Following Guselkumab Use: A Self-Controlled Risk Interval Signal Identification Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/trends-single-dose-doxycycline-lyme-disease-prophylaxis Trends in Single-Dose Doxycycline for Lyme Disease Prophylaxis in the United States: A Second Descriptive Analysis Analyses
Trends in Single-Dose Doxycycline for Lyme Disease Prophylaxis in the United States: A Second Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/trends-single-dose-doxycycline-lyme-disease-prophylaxis-0 Trends in Single-Dose Doxycycline for Lyme Disease Prophylaxis in the United States: A Descriptive Analysis Analyses
Trends in Single-Dose Doxycycline for Lyme Disease Prophylaxis in the United States: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/clozapine Clozapine & Adherence to Absolute Neutrophil Count (ANC) Monitoring and Neutropenia Studies
Clozapine & Adherence to Absolute Neutrophil Count (ANC) Monitoring and Neutropenia
Studies
https://sentinelinitiative.org/methods-data-tools/methods/evaluate-use-dance-algorithm-find-disconnected-negative-controls-and Evaluate the Use of the DANCE Algorithm to Find Disconnected Negative Controls and Develop a Toolkit Methods, Data, & Tools
Evaluate the Use of the DANCE Algorithm to Find Disconnected Negative Controls and Develop a Toolkit
Methods, Data, & Tools
https://sentinelinitiative.org/studies/drugs/covid-19-pregnancy COVID-19 in Pregnancy & Drug Utilization, Disease Severity, Adverse Neonatal Outcomes, and Adverse Maternal Outcomes Studies
COVID-19 in Pregnancy & Drug Utilization, Disease Severity, Adverse Neonatal Outcomes, and Adverse Maternal Outcomes
Studies
https://sentinelinitiative.org/news-events/publications-presentations/high-dimensional-multiple-imputation-hdmi-partially-observed High-Dimensional Multiple Imputation (HDMI) for Partially Observed Confounders Including Natural Language Processing-Derived Auxiliary Covariates Publications and Presentations
High-Dimensional Multiple Imputation (HDMI) for Partially Observed Confounders Including Natural Language Processing-Derived Auxiliary Covariates
Publications and Presentations
https://sentinelinitiative.org/news-events/publications-presentations/interplay-adverse-events-spontaneous-reporting-and Interplay of Adverse Events, Spontaneous Reporting, and Longitudinal Electronic Health Records for Signal Management Publications and Presentations
Interplay of Adverse Events, Spontaneous Reporting, and Longitudinal Electronic Health Records for Signal Management
Publications and Presentations
https://sentinelinitiative.org/news-events/publications-presentations/practical-overview-real-life-challenges-leveraging-ehr-data A Practical Overview of Real-Life Challenges Leveraging EHR Data for the FDA Sentinel System Publications and Presentations
A Practical Overview of Real-Life Challenges Leveraging EHR Data for the FDA Sentinel System
Publications and Presentations
https://sentinelinitiative.org/news-events/publications-presentations/cautionary-note-plasmode-simulation-studies-setting-causal A Cautionary Note for Plasmode Simulation Studies in the Setting of Causal Inference Publications and Presentations
A Cautionary Note for Plasmode Simulation Studies in the Setting of Causal Inference
Publications and Presentations
https://sentinelinitiative.org/news-events/publications-presentations/characteristics-and-medication-use-patterns-pregnancies Characteristics and Medication Use Patterns of Pregnancies With COVID-19 Ending in Live-Birth in the Sentinel System Publications and Presentations
Characteristics and Medication Use Patterns of Pregnancies With COVID-19 Ending in Live-Birth in the Sentinel System
Publications and Presentations
https://sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-routine-querying-system Sentinel Routine Querying System Methods, Data, & Tools
Sentinel Routine Querying System
Methods, Data, & Tools
https://sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-routine-querying-system-reporting-tool Sentinel Routine Querying System Reporting Tool Methods, Data, & Tools
Sentinel Routine Querying System Reporting Tool
Methods, Data, & Tools
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-patterns-inhaler-triple-therapy-patients-chronic Utilization Patterns of Inhaler Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Descriptive Analysis Analyses
Utilization Patterns of Inhaler Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/prescriptions-and-dispensings-central-nervous-system-cns Prescriptions and Dispensings of Central Nervous System (CNS) Stimulants: A Descriptive Analysis Analyses
Prescriptions and Dispensings of Central Nervous System (CNS) Stimulants: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2022-first Duration of Follow Up for New Molecular Entities Approved in 2022: First Descriptive Analysis Analyses
Duration of Follow Up for New Molecular Entities Approved in 2022: First Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/livdelzi-seladelpar Assessment of ARIA Sufficiency: Livdelzi (seladelpar) Sufficiency Assessments
Assessment of ARIA Sufficiency: Livdelzi (seladelpar)
Sufficiency Assessments
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/valsartan-and-non-valsartan-angiotensin-receptor-blocker-1 Valsartan and Non-Valsartan Angiotensin Receptor Blocker Utilization in Canada Following Recalls Due to Nitrosamine Impurities: A Descriptive Analysis Analyses
Valsartan and Non-Valsartan Angiotensin Receptor Blocker Utilization in Canada Following Recalls Due to Nitrosamine Impurities: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/valsartan-and-non-valsartan-angiotensin-receptor-blocker Valsartan and Non-Valsartan Angiotensin Receptor Blocker Utilization in Denmark Following Recalls Due to Nitrosamine Impurities: A Descriptive Analysis Analyses
Valsartan and Non-Valsartan Angiotensin Receptor Blocker Utilization in Denmark Following Recalls Due to Nitrosamine Impurities: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/valsartan-and-non-valsartan-angiotensin-receptor-blocker-0 Valsartan and Non-Valsartan Angiotensin Receptor Blocker Utilization in the United Kingdom Following Recalls Due to Nitrosamine Impurities: A Descriptive Analysis Analyses
Valsartan and Non-Valsartan Angiotensin Receptor Blocker Utilization in the United Kingdom Following Recalls Due to Nitrosamine Impurities: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/valsartan-and-non-valsartan-angiotensin-receptor-blocker-2 Valsartan and Non-Valsartan Angiotensin Receptor Blocker Utilization in the United States Following Recalls Due to Nitrosamine Impurities: A Descriptive Analysis Analyses
Valsartan and Non-Valsartan Angiotensin Receptor Blocker Utilization in the United States Following Recalls Due to Nitrosamine Impurities: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-gimoti-metoclopramide-nasal-spray-1 Characterization of Gimoti (Metoclopramide Nasal Spray) Dispensing Patterns: A Third Descriptive Analysis Analyses
Characterization of Gimoti (Metoclopramide Nasal Spray) Dispensing Patterns: A Third Descriptive Analysis
Analyses
https://sentinelinitiative.org/news-events/publications-presentations/assessing-treatment-effects-observational-data-missing Assessing Treatment Effects in Observational Data with Missing Confounders: A Comparative Study of Practical Doubly-robust and Traditional Missing-data Methods Publications and Presentations
Assessing Treatment Effects in Observational Data with Missing Confounders: A Comparative Study of Practical Doubly-robust and Traditional Missing-data Methods
Publications and Presentations
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-patterns-single-and-multiple-inhaler-triple Utilization Patterns of Single and Multiple Inhaler Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Descriptive Analysis Analyses
Utilization Patterns of Single and Multiple Inhaler Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-confounding-covariates-trinetx-descriptive Characterization of Confounding Covariates in the TriNetX: A Descriptive Analysis Analyses
Characterization of Confounding Covariates in the TriNetX: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/leqselvi-deuruxolitinib Leqselvi (Deuruxolitinib) & Acute Myocardial Infarction, Deep Vein Thrombosis, Pulmonary Embolism & Stroke Studies
Leqselvi (Deuruxolitinib) & Acute Myocardial Infarction, Deep Vein Thrombosis, Pulmonary Embolism & Stroke
Studies
https://sentinelinitiative.org/studies/drugs/glucagon-peptide-1-receptor-agonists-glp-1-ras Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) & Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) Studies
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) & Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Studies
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-non-arteritic-anterior-ischemic-optic-neuropathy-naion Risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) Following Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Use in Patients with Type 2 Diabetes Mellitus Analyses
Risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) Following Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Use in Patients with Type 2 Diabetes Mellitus
Analyses
https://sentinelinitiative.org/methods-data-tools/methods/comparison-signal-detection-and-evaluation-study-designs-inform Comparison of Signal Detection and Evaluation Study Designs to Inform Development of the Pregnancy Safety Framework Methods, Data, & Tools
Comparison of Signal Detection and Evaluation Study Designs to Inform Development of the Pregnancy Safety Framework
Methods, Data, & Tools
https://sentinelinitiative.org/studies/drugs/tremfya-guselkumab-0 Tremfya (Guselkumab) & Signal Identification Studies
Tremfya (Guselkumab) & Signal Identification
Studies
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2025-ispe-annual-meeting 2025 ISPE Annual Meeting Sentinel Initiative Events 08/22/2025
2025 ISPE Annual Meeting
Sentinel Initiative Events